Mapping Lymph Drainage Paths in People With Throat Cancer
Tests a new imaging and surgical method to find sentinel lymph nodes in throat cancer.
Key facts
- Who runs it
- University College, London
- Where
- London, United KingdomSee the 2 sites
- Trial code
- Registry title
- Lymphatic Mapping Of Oropharyngeal Cancer
- Status
- Recruiting
- People taking part
- 150 people, planned
- Started
- 7 Jul 2022
- Expected to end
- Jan 2027
- Type of study
- Interventional, 2 groups
- Treatments tested
- Imaging procedure
- Surgical procedure
- Record updated
- 19 September 2024
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with newly diagnosed oropharyngeal cancer and a cancer spread to lymph nodes on one side of the neck.
- Age
- 18 years or older
- Sex
- All sexes can join
- Disease stage
- New diagnosis of oropharyngeal cancer, any part of the oropharynx, HPV positive or negative. Lymph node spread on one side only: AJCC TNM8 clinical stage N1-N2b if P16 negative, N1 if P16 positive.
- Earlier treatment
- No earlier radiotherapy or surgery to the neck.
- Biomarker or test result
- HPV status can be either; P16 status sets the allowed lymph node stage (N1-N2b if P16 negative, N1 if P16 positive).
Main reasons for not taking part
- Suspicious lymph nodes on both sides of the neck on imaging
- Previous radiotherapy or surgery to the neck
- A second primary oropharyngeal tumour
- Distant metastasis, for example in the lung or bone
- Pregnancy or breastfeeding
The registry criteria, word for word
Show all 10 criteriaShow less
Who can take part
- Adults aged 18 or over
- New diagnosis of OPC - all anatomical subsites and HPV status accepted
- Unilateral metastatic nodes equating to AJCC TNM8 clinical staging N1-N2b for P16 negative and N1 for P16 positive patients
Who cannot take part
- Previous radiotherapy or surgery to the neck
- Allergy to lymphatic tracers
- Suspicious bilateral nodes on imaging
- Second primary oropharyngeal tumours
- Distant metastasis (e.g. lung, bone)
- Pregnancy and lactation
- Inability to give informed consent
This trial is currently available in United Kingdom.
- St. George's University Hospitals NHS Foundation TrustLondon, United KingdomContact: Enyi OfoTaking people
- University College HospitalLondon, United KingdomContact: Clare SchillingTaking people
About the trial
What the trial wants to find out
A multi-centre validation study to evaluate whether a new imaging and surgical protocol would work as well as the current gold standard in identifying sentinel nodes in patients with oropharyngeal cancer.
The 2 groups in the trial
- Imaging PhaseTreatment being tested
During routine examination under anaesthetic 4 x peritumoural injection of investigator's choice of 99mTc-human albumin colloidal particles or Lymphoseek (lymphatic mapping tracer) followed by freehand SPECT scan
Treatment: Imaging procedure
- Surgical PhaseTreatment being tested
Excision of contralateral nodes identified on imaging \*(fhSPECT or SPECT/CT\*) during routine examination under anaesthetic. Serial sectioning of excised (sentinel) nodes to identify micrometastasis.
Treatment: Surgical procedure
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Prospective, Multi-Centre, Phase II Validation Study for a Lymphatic Imaging Protocol in Establishing Drainage Patterns in Patients With Oropharyngeal Cancer
- Plain-language title
- Mapping Lymph Drainage Paths in People With Throat CancerGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Publications
- Record updated
- 19 September 2024